No. of Recommendations: 5
Pfizer is now trading below its price 10 years ago. It is down 38% for the year.
I am not sure the chart I see in Seeking Alpha is adjusted for spin-offs like Zoetis and Viatris. Zoetis has performed well since spin-off.
Pfizer, like Citi and AT&T seems to be a permanent presence on the Falling Knives board. All the COVID windfall pissed away on costly acquisitions, to fill pipelines their own R&D can’t deliver.
Anyone see light at the end of the tunnel? For the perennially optimistic, call options are fairly cheap.
